title: Outcomes of using Firebird rapamycin eluting stents in routine coronary intervention practice: one-year results from the pilot study of Firebird in China registry.
authors.affiliation: Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China. liuhaibono1@hotmail.com
authors.forename: Hai-bo
authors.initials: HB
authors.lastname: Liu
authors.forename: Bo
authors.initials: B
authors.lastname: Xu
authors.forename: Run-lin
authors.initials: RL
authors.lastname: Gao
authors.forename: Yue-jin
authors.initials: YJ
authors.lastname: Yang
authors.forename: Min
authors.initials: M
authors.lastname: Yao
authors.forename: Xue-wen
authors.initials: XW
authors.lastname: Qin
authors.forename: Yong-jian
authors.initials: YJ
authors.lastname: Wu
authors.forename: Jin-qing
authors.initials: JQ
authors.lastname: Yuan
authors.forename: Wei-hua
authors.initials: WH
authors.lastname: Ma
authors.forename: Shu-bin
authors.initials: SB
authors.lastname: Qiao
authors.forename: Ji-lin
authors.initials: JL
authors.lastname: Chen
mesh_terms: D000328:Adult; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D003327:Coronary Disease / Q000628:therapy*; D016503:Drug Delivery Systems; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012042:Registries; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus